VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,139 | -10.6% | 4,130 | 0.0% | 0.03% | -13.3% |
| Q2 2023 | $124,355 | -6.9% | 4,130 | 0.0% | 0.03% | -16.7% |
| Q1 2023 | $133,606 | +12.9% | 4,130 | 0.0% | 0.04% | +5.9% |
| Q4 2022 | $118,366 | +18.4% | 4,130 | 0.0% | 0.03% | +6.2% |
| Q3 2022 | $100,000 | -47.9% | 4,130 | -41.3% | 0.03% | -45.8% |
| Q2 2022 | $192,000 | -34.7% | 7,030 | -8.3% | 0.06% | -25.3% |
| Q1 2022 | $294,000 | +10.9% | 7,665 | -7.4% | 0.08% | +21.5% |
| Q4 2021 | $265,000 | +8.6% | 8,275 | 0.0% | 0.06% | -9.7% |
| Q3 2021 | $244,000 | -17.8% | 8,275 | -5.3% | 0.07% | -16.3% |
| Q2 2021 | $297,000 | +4.6% | 8,740 | 0.0% | 0.09% | 0.0% |
| Q1 2021 | $284,000 | -9.8% | 8,740 | 0.0% | 0.09% | -13.1% |
| Q4 2020 | $315,000 | -7.9% | 8,740 | 0.0% | 0.10% | -16.8% |
| Q3 2020 | $342,000 | -35.3% | 8,740 | -39.3% | 0.12% | -31.2% |
| Q2 2020 | $529,000 | +163.2% | 14,410 | +64.9% | 0.17% | +127.6% |
| Q1 2020 | $201,000 | +3920.0% | 8,740 | +3572.3% | 0.08% | +3700.0% |
| Q3 2017 | $5,000 | +25.0% | 238 | +19.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |